Latham & Watkins LLP represented SQZ Biotechnologies Company in the transaction. Goodwin Procter LLP advised the underwriters on the deal. SQZ Biotechnologies Company (NYSE: SQZ) (“SQZ”)…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now